Drug Information Cost Analysis 24-6-2012

No Date
Questioner Name Nat
Sex
Type of Questioner
Qualification
Work Pt's Name Address/De pt KSMC NA
ID
1-Oct-12
Dr.Hafiz
NA
Physician
Consultant
NA
5-Oct-12 8-Oct-12 8-Oct-12
Dr.Omar Dr.Nanamiya Dr.Safer Almurai
NA
physician Physician Physician
Resident Na Resident
KSMC KSMC KSMC
NA NA NA
NA NA 397420
Bangladeshi M NA M
10-Oct-12 13-Oct-12
Dr.Nanamiya Dr.Nanamiya
Bangladeshi M Bangladeshi M
Physician Physician
Consultant Consultant
KSMC KSMC
NA NA
469552 NA
13-Oct-12 15-Oct-12
Dr.Haitham Dr.Mohammad
Saudi NA
M M
Physician Physician
Consultant Resident
KSMC KSMC
NA NA
NA NA
16-Oct-12 16-Oct-12 16-Oct-12 17-Oct-12 20-Oct-12 20-Oct-12 31-Oct-12 3-Nov-12 4-Nov-12 10-Nov-12
Dr.Sammy Dr.Obeid Dr.Sohail Sis.Nancy Dr.Hafiz Dr.Hafez Sis.Bincy Dr.Safar Dr.Abdullah Dr.Hafiz
Sudanese Saudi NA Indian NA NA Indian NA NA NA
M M F F M M F M M M
Physician Physician Physician Nurse Physician Physician Nurse physician Physician Physician
Resident Specialist Resident NA Consultant Consultant NA NA Na Consultant
KSMC KSMC KSMC KSMC KSMC KSMC KSMC KSMC KSMC KSMC
NA NA NA NA NA NA NA NA NA NA
601061 NA NA NA NA NA 433539 NA NA NA
11-Nov-12 11-Nov-12 11-Nov-12 14-Nov-12
Dr.Nawal Al-Harbi NA Dr.Aseera NA
F F M F
Physician Pharmacist physician Physician
NA NA NA Consultant
KSMC DPIC KSMC KSMC
NA NA NA NA
NA NA NA NA
Dr.Sabar Hussain NA Dr.Farida NA
17-Nov-12
Dr. Reem
Egyptian
Pharmacist
NA
NA
NA
NA
19-Nov-12 20-Nov-12
Khalid Otaibi Dr. Abdullah AlMajed
Saudi Saudi
M M
Physician Physician
Others Consultant
NA KSMC
NA NA
NA NA
20-Nov-12 21-Nov-12
Dr.Saleh Al-Sehr Dr.Manah
Saudi Egyptian
M F
physician Physician
Consultant NA
KSMC KSMC
NA NA
NA NA
24-Nov-12 1-Dec-12
Dr.Abdulrahman Hamed
Saudi NA
M M
Physician Other
NA NA
KSMC KSMC
NA NA
NA NA
3-Dec-12 10-Dec-12 11-Dec-12
Dr. Tarek Dr.Hafez Dr.Kamal
Saudi NA NA
M M M
Physician Physician Physician
Consultant Consultant Senior Registrar Consultant
KSMC KSMC KSMC
NA NA NA
NA NA NA
12-Dec-12
Dr.Abdulrahman Al- Saudi Sehri Dr.Salaha Dr.Amir Ahmad NA Saudi Saudi
Physician
KSMC
NA
NA
17-Dec-12 22-Dec-12 12-Dec-12
F M M
physician Physician NA
Registrar Registrar NA
KSMC T1B3 KSMC
NA NA NA
NA NA NA
20-Dec-12 24-Dec-12 25-Dec-12 30-Dec-12
Dr.Radwan Dr.Ayman Hana Dr.Abdulmajed
NS Saudi NA NA
M M F M
Physician Physician Pharmacist Physician
Consultant NA NA Consultant
KSMC KSMC Pharmacy KSMC
NA NA NA NA
NA NA NA NA
Nat
Sex Wt
Diagnosis
Ward
Type of Question Question
Answer
NA
NA
NA
NA
NA
Others
Is the action of clopidogrel Answer given reversable or irreversable? How to calculate GFR? Availability of tazocin Dose of warfarin to achieve therapeutic INR level Availability of albumin Answer given Answer given Answer given
NA NA NA
NA NA M
NA NA NA
NA NA NA
NA NA NA
Pharmacokinetic Drug Availability Dosage Administration Drug Availability General Information General Information Drug-Drug Interaction Drug Interactions Drug availability General Information Drug Availability Others
NA NA
F F
NA NA
NA NA
T1A4 NA
Answer given
NA NA
F NA
NA NA
NA NA
NA NA
N.acetylcysteine dose in Answer given pulmonary disease and its availability Use of N.acetylcysteine Answer given Is there drug drug Answer given interaction between warfarin and phenobarbital? Drug drug interaction of Answer given captopril anf kcl Availability of meropenem Same day Drug causing properam Availability of levedopa Answer given Answer given During the hospitalization period. Answer given Answer given 1-3 mg in our hospital. Same day Answer given
M NA NA NA NA NA NA NA NA NA
T1A3 NA NA NA NA NA NA NA NA NA
Duration of clexane in ACS pt? Others Wich is better ACS atrovastin or simvastatin Dosage/Administra How to dilute vigra? tion Drug Availability warfarin availability in how much concentration Drug Availability Availability of rabbies vaccine Others Does the benefits of using warfarin,aspirin,and clopidogrel outweighs the risk? Adverse Drug Reaction Dosage/Administra tion Therapeutic Use Others Docusta sodium used in pregnancy ? Wich antibiotic consider during fistula surgery? Cotrimoxazole dose? Can we put manitol in boiling water to remove crystals?
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
Answer given Answer given Answer given Answer given
NA
NA
NA
NA
NA
Pharmacokinetic
NA NA
NA NA
NA NA
NA NA
NA NA
Others Poisoning
NA NA
NA NA
NA NA
NA NA
NA NA
Pharmacokinetic Poisoning
NA NA
NA NA
NA NA
NA NA
NA NA
Adverse Drug Reaction Poisoning
Neonate start on vancomycin fot catheter related to infection MRSA in blood low level,what shall we do? Is cigarette is carcinogenic? Pt.is having spastisity,unresponsivenes s,dialated pupils,non reactive and respiratory distress what medications can do this? Pharmacokinetic of morphine How to manage cosmetic poisoning in pediatric patient Medication that may cause thrombocytopnea Pt. took 2 tabs of thyroxine dose 200 mg,she is ok no sign and symptoms shall I take her to ER? The usual dose of clindamycin? What is the drug of choice in heart block? Can be used spironolactone in combination with ACE'I and lasix What is the adverse drug reaction of octreoticide on blood? Other drug for vertigo
Answer given
Answer given Narcotics
Answer given Answer given
Answer given No need to bring her in ER,no sign and symptoms,its not a toxic dose Answer given Answer given Answer given
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
Dose Standardization Others Others
NA
NA
NA
NA
NA
Adverse Drug Reaction Drug Availability
Answer given
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
Answer given Yes No major drug drug interaction Yes Answer given Yes it can Answer given
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
Drug Administation Can we give heparin 5000 IU as SQ? Drug-Drug Drug drug interaction of Interaction zestril,warfarin,amlor,lasix, atenolol,and kepra Drug coverage does tazocin covers anerobes? Drug Identification Mechanism of action of octreokide in chylothorax Pharmacokinetic Can chronovalporate be given 12 hrs? Dosage Coverage Is Fluconazole is the drug of choice for candidia?
Total Cost Saving ($)
MI Data Bank Documente d No
Question Was Answered Yes
Level
Description
Cost
95% Cl
Total Cost impact of DPIC Inquiries
NA
NA
NA
NA
NA
No No No
Yes Yes Yes
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
No No
Yes Yes
NA NA
NA NA
NA NA
NA NA
NA NA
No No
Yes Yes
NA 3a
NA Additional Tests
NA 95.00
NA 73-116
NA NA
No No No No No No No NA NA No
Yes Yes Yes Yes Yes Yes Yes NA NA Yes
NA NA NA NA V NA NA NA NA NA
NA NA NA No
NA NA NA Yes
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
No
Yes
3a;4b
additional tests;additional 95;411.00 treatment /non invasive procedure NA NA NA NA
73-116;267- NA 554
No No
Yes Yes
NA NA
NA NA
NA NA
NA NA
NA Yes
NA NA
NA NA
NA NA
NA NA
NA NA
No No
Yes Yes
NA NA
NA NA
NA NA
NA NA
NA NA
No No No
Yes Yes Yes
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
No
Yes
NA
NA
NA
NA
NA
No No No
Yes Yes Yes
NA 1 NA
NA No change in therapy or no harm NA
NA 0.00 NA
NA NA NA
NA NA NA
No No No No
Yes Yes Yes Yes
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
Severity Rating
Physician Visit
Additional Tests
Additional Treatment
Noninvasiv Invasive Increased e Procedure LOS Procedure NA NA NA
ICU Transfer
LTC Admission
NA
NA
NA
NA
NA
NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA
NA
NA
NA
NA
NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
Death
Total
Sensitivity Notes Analysis
Pharmacist Reporting
NA
NA
NA
NA
Amal AlAqqad Amal AlAqqad Dr.Moin Khaja Dr.Moin Khaja Dr.Moin Khaja Dr.Moin Khaja Dr.Moin Khaja Dina Fouda
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA
NA NA
NA NA
NA NA
NA
NA NA
NA NA
NA NA
Dr.Moin Khaja Dr.Moin Khaja Dr.Moin Khaja Dr.Moin Khaja Amal AlAqqad Amal AlAqqad Dr.Moin Khaja Dr.Moin Khaja Dr.Moin Khaja Amal AlAqqad
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
Dr.Moin Khaja Dr.Moin Khaja Dr.Moin Khaja Amal AlAqqad
NA
NA
NA
NA
Aseera AlSarhan
NA NA
NA NA
NA NA
NA NA
Aseera AlSarhan Amal AlAqqad
NA NA
NA NA
NA NA
NA NA
Suzan Asfour Amal AlAqqad Suzan Asfour Amal AlAqqad
NA NA
NA NA
NA NA
NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
Suzan Asfour Amal AlAqqad Amal AlAqqad Suzan Asfour Dr.Moin Khaja Dina Fouda Amal AlAqqad Suzan Asfour Suzan Asfour Amal AlAqqad Sara Salem
NA
NA
NA
NA
NA NA NA
NA 0 NA
NA NA NA
NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
NA NA NA NA
Month
No. of Question Percentage
Type of Question Poisoning Drug Identification Drug Availability
No.
Percentage
January
15
100%
46.7%
Total
15
100%
3 2 1 1
20.0% 13.3% 6.7% 6.7%
Type of Questioner Physician
No. 12
Percentage 80%
Dosage Administration Dose Standardization General Information Total
Dentist
6.7%
6.7%
Intern Nurse Total
1 1 15
6.7% 6.7% 100%
15
100%
Month
Total Cost Saving ($) 701080.00
January Qualification of Questioner Consultant NA Senior Registrar Registrar Intern Total Work Address
No. 6 4
Percentage 40% 27%
Total
701080.00
2 2 1 15 No.
13% 13% 7% 100% Percentage
Pediatric Hospital NA General Hospital Dental Hospital Total
7 4 3 1 15
47% 27% 20% 7% 100%
DPIC QUESTION JANUARY 2012

15
TYPE OF QUESTION
16 14 12 10 8 6
100% 7
3 2 1 1
4 2 0
No. of Question
Percentage
Reporting Pharmacist Yousef Al-Omi Hajer AlMudaiheem Khaja Moinuddin Joza Al-Otaibi Dina Fouda
No. of Question
Total Cost ($) 600000.00
Reporting Type of Pharmacist Question Yousef AlOmi Total Poisoning
No.
Percentage
100%
3 2 2 1
100129.00 951.00 0.00 0.00
100%
Reporting Type of Pharmacist Question Dosage Hajer AlAdministr Mudaiheem ation Poisoning Dose Standardi zation Total
No. 1
Percentage 33.3%
Nora Al-Juhani
0.00
33.3%
Total
15
701080.00
1 3
33.3% 100%
Reporting Pharmacist Yousef Al-Omi Hajer AlMudaiheem Khaja Moinuddin Joza Al-Otaibi
No. of Question
Percentage
40%
3 2 2
20% 13.3% 13.3%
Dina Fouda Nora Al-Juhani Total
1 1 15
6.7% 6.7% 100%
OF QUESTION
15
TYPE OF QUESTIONER
16 14 12 10 8 6 4 2 0
16 14 12 10 8 6 4 2 0 Physician Dentist Intern Nurse

1 1 1 12
15
Total
Reporting Pharmacist
Type of Question
No.
Percentage
Severity Rating 1
No.
Percentage
Khaja General Moinuddin Information Drug Availability Total
50%
23.5%
1 2
50% 100%
2 4b 6
4 2 7 17
23.5% 11.8% 41.2% 100%
Reporting Pharmacist Joza AlOtaibi Total
Type of Question Drug Identificatio n
No.
Percentage
Total
100%
100%
Type of Question
No.
Percentage
Drug Dina Fouda Identificatio n Total
100%
100%
Reporting Pharmacist Nora AlJuhani Total
Type of Question Drug Availability
No.
Percentage
1 1
100% 100%
Month
Type of Question Poisoning General Information Drug Identification
No.
Percentage
February
29
100%
10
33.3%
Total
29
100%
7 4 3
23.3% 13.3% 10.0%
Type of Questioner Physician Intern Clinical Pharmacist Total
No.
Percentage
Dosage Administration Dose Standardization Therapeutic Use Drug-Drug Interaction Drug Availability Total
26 2 1
89.7% 6.9% 3.4%
2 2 1
6.7% 6.7% 3.3%
29
100%
1 30
3.3% 100%
Qualification of Questioner Resident
No.
Percentage
12
41.4%
Registrar Consultant Intern Senior Registrar Clinical Pharmacist Total
8 5 2 1
27.6% 17.2% 6.9% 3.4% Month February Total Cost Saving ($) 1006772.5
1 29
3.4% 100%
Total
1006772.5
DPIC QUESTION FEBRUARY 2012
Work Address Pediatric Hospital NA General Hospital Total
No. 9 9 11 29
Percentage
30
29
31% 31% 37.9%
25 20 15 10
100%
5 0
100%
No. of Question
Percentage
Reporting Pharmacist Yousef Al-Omi
No. of Question
Total Cost ($) 900000.00
Reporting Pharmacist Yousef AlOmi Total
Type of Question Poisoning
No.
Khaja Moinuddin Hajer AlMudaiheem Joza Al-Otaibi
9 5 2
6189.50 583.00 0.00
Type of Question
No.
Dina Fouda Nora Al-Juhani Total
2 2 29
0.00 100000.00 1006772.50
Dosage Hajer AlAdministratio Mudaiheem n Drug-Drug Interaction Drug Identification Dose Standardizati on
2 1 1
1 5
No. of Question 9
Percentage 31%
Total
Khaja Moinuddin Hajer AlMudaiheem Joza Al-Otaibi Dina Fouda Nora Al-Juhani
31.0%
5 2 2 2
17.2% 6.9% 6.9% 6.9%
Total
29
100%
TYPE OF QUESTIONER
29
30 25 20 15 10
100%
26
5 0 Physician
Percentage
Intern
Clinical Pharmacist
Total
Percentage
Reporting Pharmacist Khaja Moinuddin
Type of Question General Information Dosage Administratio n Drug Availability Therapeutic Use
No.
Percentage
Severity Rating 1
No.
100%
70%
100%
1 1 1
10% 10% 10%
2 4a 4b
11 3 7
Percentage
40.0% 20.0% 20.0%
Total
10
100%
4c 6 Total
1 10 38
20.0% 100% Reporting Pharmacist Joza AlOtaibi Type of Question Drug Identification Dose Standardizatio n Total No. Percentage
50%
1 2
50% 100%
Reporting Pharmacist Dina Fouda
Type of Question Drug Identification Therapeutic Use
No.
Percentage
1 1
50% 50%
Total Reporting Pharmacist Nora AlJuhani Type of Question Poisoning Drug Identification Total
100%
No. 1 1 2
Percentage 50% 50% 100%
TYPE OF QUESTION
30 20 10 0
10 7 4 3 2 2 1 1 30
Percentage
15.8%
28.9% 7.9% 18.4%
2.6% 26.3% 100%
Month
Type of Question
No.
Percentage
March
25
100%
Poisoning Drug Availability/For mulary Dose Standardization
10
38.5%
Total
25
100%
26.9%
6 2 1
23.1% 7.7% 3.8%
No. 22
Percentage 88.0%
Therapeutic Use Drug Administration Total
Pharmacist GS Total
2 1 25
8.0% 4.0% 100%
26
100%
Qualification of Questioner Registrar Resident Consultant Senior Registrar Total
No. 6 4 13 2 25
Percentage 24.0% 16.0% 52.0% 8.0% 100% Month March Total Total Cost Saving ($) 1001792 1001792
DPIC QUESTION MARCH 2012

Work Address General Hospital No. 23 Percentage 92.0%
25 20
25
Pediatric Hospital MOH Total
20
1 1 25
4.0% 4.0% 100%

15 10 5 0 No. of Question
No. of Question
Total Cost ($)
Type of Question
Yousef Al-Omi
10
1000000.00
Dose Aseera AlStandardizati Sarhan on Total
Hajer AlMudaiheem Khaja Moinuddin Aseera Al-Sarhan Rawan Zmeili
614
5 1 1
951 0 227 Type of Question Dose Standardizati on Drug Hajer AlAvailability/F Mudaiheem ormulary Total Reporting Pharmacist
Total
25
1001792.00
Reporting Pharmacist Yousef Al-Omi Hajer AlMudaiheem Khaja Moinuddin Aseera Al-Sarhan Rawan Zmeili Total
No. of Question
Percentage
10 8 5 1 1 25
40.0% 32.0% 20.0% 4.0% 4.0% 100%
DPIC QUESTION MARCH 2012

25 20 15
22
TYPE OF QUESTIONER
15 10 5
100% 2 1
0 Physician Percentage Pharmacist GS
No.
Percentage
Type of Question
No.
Percentage
Severity Rating
100%
Drug Khaja Availability/ Moinuddin Formulary Drug Administrati on Total
80%
100%
20%
100%
6 4a
No. 5
Percentage 62.5% Reporting Pharmacist Rawan Zmeili Total Reporting Pharmacist Yousef AlOmi Total Type of Question Poisoning Type of Question Therapeutic Use No. Percentage
4b
3 8
37.5% 100%
1 1
100% 100%
Total
No.
Percentage
10 10
100% 100%
TYPE OF QUESTION
25
30 20
10
26
10
10 0
6 2 1
Total
No.
Percentage
18.5%
29.6%
10 2 2
37.0% 7.4% 7.4%
27
100%
Month
Type of Question
No.
Percentage
April
20
100%
Poisoning Drug Availability/For mulary Dose Standardization
11
52.4%
Total
20
100%
14.3%
19.0%
No.
Percentage
Drug Administration Compatibility
9.5%
17
85.0%
4.8%
Nurse
15.0%
Total
21
100%
Total
20
100%
Qualification of Questioner Registrar Resident Staff Nurse Consultant Total
No. 4 3 3 10 20
Percentage 20.0% 15.0% 15.0% 50.0% 100% Month April Total Total Cost Saving ($) 1100604.50 1100604.50
DPIC QUESTION APRIL 2012

Work Address No. Percentage
20
20
General Hospital Pediatric Hospital Total
10 10 20
50% 50% 100%
20 15 10 5 0 No. of Question Percentage
30 20 10 0
No. of Question
Total Cost ($)
Type of Question
Yousef Al-Omi
10
1000000.00
Dose Dina Fouda Standardizati on Drug Administratio n Total
Hajer AlMudaiheem Khaja Moinuddin
129.00
475.50
Nora Al-Juhani
100000.00 Reporting Pharmacist Type of Question
Dina Fouda
Total
20
1100604.50
Dose Standardizati on Drug Hajer AlAdministratio Mudaiheem n Compatibility
Reporting Pharmacist Yousef Al-Omi Hajer AlMudaiheem Khaja Moinuddin Nora Al-Juhani Dina Fouda Total
No. of Question 10 4 3 2 1 20
Percentage 50.0% 20.0% 15.0% 10.0% 5.0% 100.0%
Total
UESTION
TYPE OF QUESTIONER
20
20
17
20 15 10 5 0 Percentage
17
100%
Physician
Nurse
Total
TYPE OF QUESTION
21
11 3 4
No.
Percentage
Type of Question
No.
Percentage
Severity Rating
50%
Drug Khaja Availability/ Moinuddin Formulary Total
100%
50%
100%
100%
4b
6 Reporting Pharmacist Nora AlJuhani Type of Question Dose Standardizat ion Poisoning Total
No.
Percentage
No.
Percentage
Total
50%
50%
1 1 4
25% 25% 100% Reporting Pharmacist Yousef AlOmi Total
1 2
50% 100%
No. 10 10
Percentage 100% 100%
No.
Percentage
28.6%
14.3%
4.8%
11
52.4%
21
100%
Month
Type of Question Poisoning Dose Standardization Therapeutic Use
No.
Percentage
May
21
100%
42.9%
Total
21
100%
14.3%
2 2 1 1 1 1 1
9.5% 9.5% 4.8% 4.8% 4.8% 4.8% 4.8%
Type of Questioner Physician Nurse Pharmacist Total
No. 19 1 1 21
Percentage 90.5% 4.8% 4.8% 100%
General Information Pharmacokinetic Drug Identification Drug Administration Adverse Drug Reaction Immunization
Total
21
100%
Qualification of Questioner Registrar NA Senior Registrar Resident Staff Nurse Consultant Total
No. 10 2 5 2 1 1 21
Percentage 47.6% 9.5% 23.8% 9.5% 4.8% 4.8% 100% Month May Total Total Cost Saving ($) 901024.50 901024.50
DPIC QUESTION MAY 2012
Work Address Pediatric Hospital General Hospital Total
No. 11 10 21
Percentage 52.4% 47.6% 100%
25 20 15 10 5 0
21
No. of Question
Percentage
25 20 15 10 5 0
No. of Question
Total Cost ($) 900000.00
Type of Question Drug Identification General information Adverse Drug Reaction Immunizatio n
Dina Fouda Hajer AlMudaiheem Rawan Zmeili Joza Al-Otaibi Aseera Al-Sarhan Total
227.00
3 2 2 1 21
0.00 343.50 454.00 0.00 901024.50 Total
No. of Question
Percentage Reporting Pharmacist Rawan Zmeili Total Type of Question Therapeutic Use
43%
Dina Fouda Hajer AlMudaiheem Rawan Zmeili Joza Al-Otaibi Aseera Al-Sarhan Total
19%
3 2 2 1 21
14% 10% 10% 5% 100%
Reporting Pharmacist Yousef AlOmi Total
QUESTION
25
TYPE OF QUESTIONER
25
19
21
20 15 10
100%
5 0
Percentage
Physician
Nurse
Pharmacist
Total
TYPE OF QUESTION
25 20 15 10 5 0
9 3 21
No.
Percentage
Type of Question Dose Standardizat ion
No.
Percentage
Severity Rating 0
25.0%
100%
25.0%
100%
1 1 4
25.0% 25.0% 100% Reporting Pharmacist Type of Question No. 1 1 Percentage 100% 100%
2 3a 3b 4a 6 Total Reporting Pharmacist Type of Question No. Percentage
Aseera Al- Pharmacoki Sarhan netic Total
No.
Percentage
Drug Hajer AlAdministrati Mudaiheem on General Information Dose Standardizat ion Total
33.3%
100%
33.3%
100%
1 3
33.3% 100%
No. 9 9
21
Total
No.
Percentage
27.3%
4.5%
1 1 1 3 9 22
4.5% 4.5% 4.5% 13.6% 40.9% 100%
Month
Type of Question Poisoning Drug Identification Drug Availability/For mulary
No.
Percentage
June
24
100%
10
40.0%
Total
24
100%
20.0%
12.0%
Type of Questioner Physician Nurse Other Clinical Pharmacist GS Nephrologist Oncologyst
No.
Percentage
Dose Standardization Drug Administration Pharmacokinetic Immunization Drug-Drug Interaction Total
8.0%
16 3 1 1 1 1 1
66.7% 12.5% 4.2% 4.2% 4.2% 4.2% 4.2%
2 1 1 1 25
8.0% 4.0% 4.0% 4.0% 100%
Total
24
100%
Qualification of Questioner Registrar Senior Registrar Staff Nurse Consultant Other Total
No. 13 4 3 3 1 24
Percentage 54.2% 16.7% 12.5% 12.5% 4.2% 100%
Month June Total
Total Cost Saving ($) 1000377.50 1000377.50
DPIC QUESTION JUNE 2012

24 25
24 25
Work Address General Hospital Pediatric Hospital Outside of Hospital Total
No. 18 5 1 24
Percentage 75.0% 20.8% 4.2% 100%
TYPE OF QUESTION
30 20
10
10 0
Reporting Pharmacist Dr.Yousef Al-Omi
No. of Question
Total Cost ($) 1000000.00
Type of Question Drug Identification Drug Administratio n Drug-Drug Interaction Immunizatio n Pharmacokin etic
10
Dina Fouda
0.00
Khaja Moinuddin
377.50
Joza Al-Otaibi
0.00
Total
24
1000377.50 Total
Reporting Pharmacist Yousef Al-Omi Dina Fouda
No. of Question 10 8
Percentage 41.7% 33.3% Reporting Pharmacist Type of Question Drug Khaja Availability/F Moinuddin ormulary Drug Administratio n Total
Khaja Moinuddin Joza Al-Otaibi Total
3 3 24
12.5% 12.5% 88%
QUESTION
30 20
16
TYPE OF QUESTIONER
20 10 0 100%
16
Percentage
F QUESTION
25
No.
Percentage
Reporting Pharmacist Joza AlOtaibi
Type of Question Dose Standardizat ion Drug Identificatio n
No.
Percentage
Severity Rating 6
50.0%
66.7%
12.5%
33.3%
12.5%
Total
100%
12.5% Reporting Pharmacist Yousef AlOmi Total Type of Question Poisoning
1 8
13% 100%
No. 10 10
3b Total
No. 3
Percentage 75%
1 4
25% 100%
24
No.
Percentage
10
40.0%
24.0%
20.0%
12.0%
1 25
4.0% 100%
Month
Type of Question Adverse Drug Reaction General Information Drug Administration
No.
Percentage
July Total
10 10
100% 100%
3 3 2
30% 30% 20%
Type of Questioner Nurse
No.
Percentage
Dose Standardization Drug Availability/For mulary Total
10%
50%
10%
Physician
30%
10
100%
Dentist
20%
Total
10
100%
Qualification of Questioner Staff Nurse Registrar Senior Registrar Total
No. 5 4 1 10
Percentage 50% 40% 10% 100%
Month July Total
DPIC QUESTION JULY 2012
DPIC QUESTION JULY 2012

10 10
Work Address General Hospital Total
No. 10 10
TYPE OF QUESTION
10 8 6 4 2 0
3 30% 3 2 30% 20% 1 10% 1
Reporting Pharmacist Aseera Al-Sarhan Dina Fouda Khaja Moinuddin
No. of Question
Total Cost ($) 0.00 0.00 3073.50
Type of Question
1 1 6
Dose Dina Fouda Standardizati on Total
Joza Al-Otaibi
159.50
Total
10
3233.00
Reporting Pharmacist Khaja Moinuddin Joza Al-Otaibi Aseera Al-Sarhan Dina Fouda Total
No. of Question
Percentage Reporting Pharmacist Type of Question Drug Aseera AlAdministratio Sarhan n Total
6 2 1 1 10
60% 20% 10% 10% 100%
QUESTION
TYPE OF QUESTIONER
QUESTION
10 8 6 4 100% 2 0 Percentage Nurse
50% 5
TYPE OF QUESTIONER
10
3 2 100% 30% 20%
Physician
Dentist
Total
F QUESTION
10
No.
1 10% 100%
Percentage
No.
Percentage
Type of Question Adverse Drug Reaction
No.
Percentage
Severity Rating 0 1 2
1 1
100% 100%
2 2
100% 100%
3a Reporting Pharmacist Type of Question
No.
Percentage
4b
Khaja General Moinuddin Information Adverse Drug Reaction Drug Administrati on Drug Availability/ Formulary No. 1 1 Percentage 100% 100% Total
50.0%
4d
16.7%
Total
16.7%
16.7%
100%
No. Percentage
100%
No.
Percentage
3 3 2
27.3% 27.3% 18.2%
9.1%
9.1%
9.1%
11
100%
Month September Total Type of Questioner Physician
No. of Question Percentage 6 6 100% 100%
No. 3
Percentage 50%
Type of Question Drug Identification Adverse Drug Reaction Drug Dilution Drug in Pregnancy Total
No. 3 1 1 1 6
Percentage 50% 16.7% 16.7% 16.7% 100%
Nurse Clinical Pharmacist Patient Total
1 1 1 6
16.7% 16.7% 16.7% 100%
Qualification of Questioner Registrar Senior Registrar Staff Nurse Patient Total
No. 2 2 1 1 6
Percentage
33.3%
Month October Total
33.3% 16.7% 16.7% 100%
DPIC QUESTION SEPTEMBER 2012

6
6
Work Address KSMC KSMC/ICU DPIC Total
No. 24 1 1 26
Percentage 92% 4% 4% 100%
5 4 3 2 1 0 No. of Question Percentage
0 No. of Question Percentage
TYPE OF QUESTION
6 5 4 3 2 1 0
Drug Identification Adverse Drug Reaction Drug Dilution Pregnancy 50% 1 16.7% 1 16.7% 3
Reporting Pharmacist Dina Fouda Fatima Al-Doligan Total
No. of Question 5 1 6
Total Cost ($) 159.50 0.00 159.50
Reporting Type of Pharmacist Question Fatima AlDrug Dilution Doligan Total Reporting Pharmacist Dina Fouda Type of Question Drug Identification Adverse Drug Reaction Drug in Pregnancy Total
Reporting Pharmacist Dina Fouda Fatima Al-Doligan Total
No. of Question 5 1 6
Percentage 83.3% 16.7% 100%
QUESTION MBER 2012

6 5 4 3 2
3
TYPE OF QUESTIONER
100%
1 50% 16.7%
1 16.7%
1 16.7%
1 0
Physician Percentage
Nurse
Clinical Pharmacist
Patient
Total
Physician Percentage
Nurse
Clinical Pharmacist
Patient
Total
QUESTION
6
1 16.7% Drug in Pregnancy Total
100%
No. 1 1
Severity Rating 0 1 2
No. 3 1 1 1 6
Percentage 50.0% 16.7% 16.7% 16.7% 100%
No. 3
Percentage 60%
3a Total
1 1 5
20% 20% 100%
100%
Total
Total
Month August Total Type of Questioner Nurse Total
No. of Question Percentage 1 1 No. 1 1 100% 100% Percentage 100% 100%
Type of Question Drug Administration Total
No. 1 1
Qualification of Questioner Resident Consultant Registrar Senior Registrar Specialist NA Total
No. 5 7 3 2 1 8 26
Percentage 19% 27% 12% 8% 4% 31% 100%
Month August
Total
184.00
DPIC QUESTION AUGUST 2012
1 0.8
Work Address General Hospital Total
No. 1 1
0.6 0.4 0.2 0 No. of Question Percentage
TYPE OF QUESTION
TYPE OF QUESTION
1 0.8 0.6 0.4 0.2 0
Drug Administration
Total
Reporting Pharmacist Fatima Al-Doligan Total
No. of Question 1 1
Total Cost ($) 184.00 184.00
Type of Question Drug Fatima AlAdministratio Doligan n Total
Reporting Pharmacist Fatima Al-Doligan Total
No. of Question 1 1
QUESTION GUST 2012
TYPE OF QUESTIONER
100%
1 0.8 0.6 0.4 0.2 0
Percentage
Nurse
Total
F QUESTION
F QUESTION
Total
No. 1 1
Severity Rating 3b Total
No. 1 1
Month October Total
No. of Percentag Question e 26 26 100% 100%
Type of Question Dosage Administration Dosage/Administr ation Dose Standardization Dose Administration Drug Availability
No. 1 1 1 1 4
Percentag e 4% 3.8% 3.8% 3.8% 15.4%
Type of Questioner Clinical Pharmacist Nurse Physician
No. 1
Percentag e 4%
5 20 26
19% 77% 100%
Drug Information Drug Interaction Drug Monitoring Drug-Drug Interaction General Information Infection Control Other
1 1 1 1 3 1 1 6 1 2 26
3.8% 3.8% 3.8% 3.8% 11.5% 3.8% 3.8% 23.1% 3.8% 7.7% 100.0%
Qualification of Questioner NA Consultant Resident Specialists
No. 3 6 5 1 15
Percentag e
20.0%
Others Pharmacokinetic Poisoning
40.0% 33.3% 6.7% 100.0%
Type of Question Dosage Administration Work Address DPIC KSMC KSMC/ICU No. 1 24 1 26 Percentag e 4% 92.3% 3.8% 100.0% Dosage/Administration Drug Availability Drug Interaction General Information Others Pharmacokinetic Drug-Drug Interaction GRAND TOTAL
Reporting Pharmacists Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Amal Aqqad Dr Amal Aqqad Dr Dina fouda
No. 1 1 4 1 3 3 1 1 15
Percentage 7% 7% 27% 7% 20% 20% 7% 7% 100%
Severity Rating 0 2 6 3a 4a NA
No. 6 2 1 1 1 15 26
Percentag e 23.1% 7.7% 3.8% 3.8% 3.8% 57.7% 100.0%
Month October
Month November
Perce ntage 100% 100%
Qualification of Questioner Consultant NA Others
No. 4 8 1 13
Percentage
30.8%
61.5% 7.7% 100.0%
Type of Questioner Pharmacist Physician
No. 2 11 13
Perce ntage 15% 85% 100%
Type of Question Adverse Drug reaction
Reporting Pharmacists Dr Khaja Moinuddin Dr Susan Asfour
No. 1 1 1 2 2 1 1 1
Percentage 8% 8% 8% 15% 15% 8% 8% 8% Type of Question Dosage Administration Dosage/Administr ation Drug Availability Drug Interaction General Information Others Reporting Pharmacists Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Amal Aqqad
Dosage Administration Drug Availability Others
Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Amal Aqqad Dr Aseera AlSarhan Dr Aseera AlSarhan Dr Susan Asfour
Pharmacokinetics
Poisoning Therapeutic use
Dr Amal Aqqad Dr Khaja Moinuddin
2 1 13
15% 8% 100%
Pharmacokinetic Drug-Drug Interaction GRAND TOTAL
Dr Amal Aqqad Dr Dina fouda
Work Address DPIC KSMC NA
No. 1 10 2 13
Percentage 8% 76.9% 15.4% 100.0%
No. 1 1 4 1 3 3
Percentage 7% 7% 27% 7% 20% 20%
1 1 15
7% 7% 100%
Type of Question Adverse Drug reaction Dosage Administration Drug Availability Others
Reporting Pharmacists Dr Khaja Moinuddin Dr Susan Asfour Dr Khaja Moinuddin Dr Khaja Moinuddin Dr Amal Aqqad Dr Aseera Al-Sarhan
No. 1 1 1 2 2 1 1 1 2 1 13
Percentage 8% 8% 8% 15% 15% 8% 8% 8% 15% 8% 100%
Severity Rating NA
No. 1
Pharmacokinetics
Dr Aseera Al-Sarhan Dr Susan Asfour Dr Amal Aqqad Dr Khaja Moinuddin
Poisoning Therapeutic use
Percentag e
Month November
Month
Percentage
Qualification of Questioner Consultant NA Registrar Senior Registrar
No.
Percentage
December
100% 100%
6 7 2 1 16
37.5%
43.8% 12.5% 6.3% 100.0%
Type of Questioner NA Nurse other Pharmacist Physician
No. 1 1 1 1 12 16
Percentage 6% 6% 6% 6% 75.0% 100.0%
Work Address KSMC NA Pharmacy T1B3
No.
Percentage
Type of Question Adverse Drug Reaction Dosage Coverage Dose Standardization
Reporting Pharmacists Susan Asfour Sara Salem Suzan Asfour Rwan Zmeili
No.
13 1 1 1 16
81% 6.3% 6.3% 6.3% 100.0%
1 1 1 2 1 1 1 2 1 1 2 1 1 16
Drug Administration Drug Availability Drug Coverage
Dina Fouda Khaja Moinuddin Suzan Asfour
Drug Identification Dina Fouda Susan Asfour Drug-Drug Interaction Others Pharmacokinetic Poisoning Amal Al-Aqqad Amal Al-Aqqad Amal Al-Aqqad Amal Al-Aqqad
Percentage
Severity Rating 1 4a NA
No.
Percentage
Month
6% 6% 6% 13% 6% 6% 6% 13% 6% 6% 13% 6% 6% 100%
3 1 12 16
18.8% 6.3% 75.0% 100.0%
December

Drug Information Cost Analysis 24-6-2012

Hochgeladen von

Dokumentinformationen

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Drug Information Cost Analysis 24-6-2012

Hochgeladen von

Copyright:

Verfügbare Formate

No Date

Questioner Name Nat

Work Pt's Name Address/De pt KSMC NA

5-Oct-12 8-Oct-12 8-Oct-12

Dr.Omar Dr.Nanamiya Dr.Safer Almurai

physician Physician Physician

KSMC KSMC KSMC

Sudanese Saudi NA Indian NA NA Indian NA NA NA

Resident Specialist Resident NA Consultant Consultant NA NA Na Consultant

11-Nov-12 11-Nov-12 11-Nov-12 14-Nov-12

Dr.Nawal Al-Harbi NA Dr.Aseera NA

Physician Pharmacist physician Physician

KSMC DPIC KSMC KSMC

Dr.Sabar Hussain NA Dr.Farida NA

Khalid Otaibi Dr. Abdullah AlMajed

Dr.Saleh Al-Sehr Dr.Manah

3-Dec-12 10-Dec-12 11-Dec-12

Dr. Tarek Dr.Hafez Dr.Kamal

Physician Physician Physician

Consultant Consultant Senior Registrar Consultant

KSMC KSMC KSMC

Dr.Abdulrahman Al- Saudi Sehri Dr.Salaha Dr.Amir Ahmad NA Saudi Saudi

17-Dec-12 22-Dec-12 12-Dec-12

KSMC T1B3 KSMC

20-Dec-12 24-Dec-12 25-Dec-12 30-Dec-12

Dr.Radwan Dr.Ayman Hana Dr.Abdulmajed

Physician Physician Pharmacist Physician

KSMC KSMC Pharmacy KSMC

Type of Question Question

Answer given Answer given Answer given Answer given

Adverse Drug Reaction Poisoning

Answer given Narcotics

Answer given Answer given

Dose Standardization Others Others

Adverse Drug Reaction Drug Availability

Total Cost Saving ($)

MI Data Bank Documente d No

Question Was Answered Yes

Total Cost impact of DPIC Inquiries

Yes Yes Yes

Yes Yes Yes Yes Yes Yes Yes NA NA Yes

additional tests;additional 95;411.00 treatment /non invasive procedure NA NA NA NA

Yes Yes Yes

Yes Yes Yes

NA No change in therapy or no harm NA

Yes Yes Yes Yes

Noninvasiv Invasive Increased e Procedure LOS Procedure NA NA NA

Sensitivity Notes Analysis

Dr.Moin Khaja Dr.Moin Khaja Dr.Moin Khaja Amal AlAqqad

Aseera AlSarhan Amal AlAqqad

Suzan Asfour Amal AlAqqad Suzan Asfour Amal AlAqqad

No. of Question Percentage

Type of Question Poisoning Drug Identification Drug Availability

20.0% 13.3% 6.7% 6.7%

Type of Questioner Physician

Dosage Administration Dose Standardization General Information Total

Intern Nurse Total

6.7% 6.7% 100%

Total Cost Saving ($) 701080.00

Percentage 40% 27%

13% 13% 7% 100% Percentage

Pediatric Hospital NA General Hospital Dental Hospital Total

47% 27% 20% 7% 100%

DPIC QUESTION JANUARY 2012